GS9857

GS9857 Struktur
1535212-07-7
CAS-Nr.
1535212-07-7
Englisch Name:
GS9857
Synonyma:
GS9857;Voxilaprevir;inhibit,antiviral,HCV Protease,Inhibitor,GS9857,pangenotypic,GS-9857,GS 9857,Voxilaprevir,infection,DAA,HCV,direct-acting antiviral;Cyclopropanecarboxamide, N-[[[(1R,2R)-2-[5,5-difluoro-5-(3-hydroxy-6-methoxy-2-quinoxalinyl)pentyl]cyclopropyl]oxy]carbonyl]-3-methyl-L-valyl-(3S,4R)-3-ethyl-4-hydroxy-L-prolyl-1-amino-2-(difluoromethyl)-N-[(1-methylcyclopropyl)sulfonyl]-, cyclic (1→2)-ether, (1R,2R)-
CBNumber:
CB93133456
Summenformel:
C40H52F4N6O9S
Molgewicht:
868.93
MOL-Datei:
1535212-07-7.mol

GS9857 Eigenschaften

Dichte
1.42±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
Löslichkeit
DMF:30.0(Max Conc. mg/mL);34.52(Max Conc. mM)
DMSO:30.0(Max Conc. mg/mL);34.52(Max Conc. mM)
Ethanol:1.0(Max Conc. mg/mL);1.15(Max Conc. mM)
Aggregatzustand
A solid
pka
4.46±0.40(Predicted)
Farbe
White to off-white

Sicherheit


GS9857 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 44)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shanghai Rochi Pharmaceutical Co.,Ltd.
21-38751876 +8615000076078
info@rochipharma.com China 431 58
Hebei Mojin Biotechnology Co., Ltd
+86 13288715578 +8613288715578
sales@hbmojin.com China 12495 58
Hebei Chuanghai Biotechnology Co,.LTD
+86-13131129325
sales1@chuanghaibio.com China 5895 58
TianYuan Pharmaceutical CO.,LTD
+86-755-23284190 13684996853
sales@tianpharm.com CHINA 304 58
Hebei Guanlang Biotechnology Co., Ltd.
+86-19930503282
alice@crovellbio.com China 8820 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226
sales@hzclap.com CHINA 6313 58
Shanxi Xuanran Import and Export Trade Co., Ltd.
+8617735180244
mike_yan@xuanranglobal.com CHINA 4022 58
AFINE CHEMICALS LIMITED
+86-0571-85134551
sales@afinechem.com China 15386 58
Baoji Guokang Healthchem co.,ltd
+8615604608665 15604608665
dominicguo@gk-bio.com CHINA 9427 58

  • GS9857
  • Voxilaprevir
  • Cyclopropanecarboxamide, N-[[[(1R,2R)-2-[5,5-difluoro-5-(3-hydroxy-6-methoxy-2-quinoxalinyl)pentyl]cyclopropyl]oxy]carbonyl]-3-methyl-L-valyl-(3S,4R)-3-ethyl-4-hydroxy-L-prolyl-1-amino-2-(difluoromethyl)-N-[(1-methylcyclopropyl)sulfonyl]-, cyclic (1→2)-ether, (1R,2R)-
  • inhibit,antiviral,HCV Protease,Inhibitor,GS9857,pangenotypic,GS-9857,GS 9857,Voxilaprevir,infection,DAA,HCV,direct-acting antiviral
  • 1535212-07-7
  • C40H52F4N6O9S
Copyright 2019 © ChemicalBook. All rights reserved